Novo Nordisk (China) Pharmaceuticals Co Ltd - Company Review
Novo Nordisk (China) Pharmaceuticals Co Ltd - Company ReviewSummary
Novo Nordisk (China) Pharmaceuticals Co Ltd (Novo Nordisk), a subsidiary of Novo Nordisk A/S is a biopharmaceutical company which provides solutions and treatment for diabetes patients. It offers products and services in the areas of diabetes and hemophilia. The company provides insulin delivery devices such as durable pen and pre-filled pen for the treatment of diabetes. Novo Nordisk also provides services for hemophilia care, growth hormone therapy and hormone replacement therapy. It offers its products for diseases such as pre-diabetes, metabolic syndrome, osteoporosis, thyroid disease, obesity among others. The company owns a research and development center for new drug development in China. Novo Nordisk is headquartered in Beijing, China.
This comprehensive company report of Novo Nordisk (China) Pharmaceuticals Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.